Signed into law in August 2022, the Inflation Reduction Act (IRA) includes provisions to lower health care and medication costs over the next several years. This article outlines a few key implications of which providers should be aware.
In recent years the VHAN Population Health Pharmacy Team has made it a priority to help patients, particularly ones with chronic illnesses, improve compliance to their prescriptions. This focus on medication adherence not only helps patients better manage their chronic diseases, but it also helps maintain consistent medical care during transitions and even reduce drug costs. It’s all part of the team’s efforts to produce better patient outcomes.
In recent months, demand for GLP1 (glucagon like peptide 1) receptor agonists has skyrocketed across the country, leaving providers inundated with prescription requests and patients frustrated with shortages. GLP1 agonists have an important place in obesity therapy. However, there are many unanswered questions about long-term side effects, cost-effectiveness and the duration of therapy. Unfortunately, current manufacturing cannot adequately meet the demand for both diabetes and obesity treatment. The VHAN Pharmacy Team has the following recommendations for navigating ongoing shortages.
Coordinated care provides multiple touchpoints to ensure that no symptom goes untreated, and no patient falls through the cracks. At Vanderbilt Health Affiliated Network (VHAN), clinical pharmacists, social workers and nurse care navigators collaborate to deliver proactive, timely care to patients who need it most.
For Population Health Clinical Pharmacist Lauren Cook, PharmD, BCPS, BCACP, VHAN’s cooperative approach means staying alert for complications that may arise unexpectedly with patients. Cook’s vigilance recently helped a 64-year-old blind patient avoid a potentially catastrophic health event.
On December 6, VHAN experts Jacky Bradley, PharmD, MBA, and Sophie Katz, MD, facilitated a Learning Exchange for network members to share best practices and learn how to leverage the resources from VHAN’s new Antibiotic Stewardship Program.
Antibiotics prevent millions of deaths each year, fighting bacterial infections that could otherwise lead to serious complications or even death. But after years of overuse and inappropriate prescription, various bacteria have become increasingly resistant to antibiotics. To ensure optimum use of antibiotics and other antimicrobial drugs at Vanderbilt University Medical Center (VUMC), a team of physicians and pharmacists created the Vanderbilt Antimicrobial Stewardship Program (VASP). Learn more about the program’s successes in this case study.
At least 30% of outpatient-prescribed antibiotics are unnecessary, sometimes leading to ER visits for adverse drug events in patients of all ages. To increase the appropriate use of antibiotics and decrease the threat of antibiotic resistance, VHAN has launched a new Antibiotic Stewardship Program, focusing on Upper Respiratory Infections (URIs) in the first phase.
As the cost of prescription drugs continues to rise, patients’ refusal or inability to pay for costly medications contributes to an estimated 125,000 deaths every year. VHAN’s Care Navigators often take a closer look at patients’ medications and collaborate with the VHAN Pharmacy team to ensure patients are taking the most effective, affordable medications.
As COVID-19 cases begin to increase again in the region, new outpatient treatment options are available that may lessen the severity of infection and reduce patients’ chances of being hospitalized or dying from the virus. VHAN encourages its members and their staff to learn more about these options to help educate themselves, their family members and their patients about their availability. Making use of these treatment options will be powerful in keeping COVID-positive patients out of the hospital, ensuring beds remain available for patients needing care of all kinds.